On May 2, Teva Pharmaceutical (NASDAQ:TEVA) released first-quarter earnings for the period ended March 31.
- Quarterly revenues grew by 24.3% because of strong performance from both the generic and branded drug segments, including TEVA's top drug, Copaxone, used to treat multiple sclerosis.
- During the first quarter of 2007, Teva repurchased 3.4 million shares for a total of $152 million.
- The company declared a cash dividend of about $0.10 for the record date of May 14, to be paid May 29.
- As of April 23, Teva had 151 drug applications awaiting final U.S. Food and Drug Administration approval.
- For the entire fiscal 2007, Teva expects to achieve $9 billion in sales and EPS between $2.20 and $2.30.
(Figures in millions, except per-share data)
Income Statement Highlights
|
Q1 2007 |
Q1 2006 |
Change | |
|---|---|---|---|
|
Sales |
$2,080.0 |
$1,673.0 |
24.3% |
|
Net Profit |
$342.0 |
($1,009.0) |
N/A |
|
EPS |
$0.42 |
($1.40) |
N/A |
|
Diluted Shares |
827.0 |
722.0 |
14.5% |
Get back to basics with a look at the income statement.
Margin Checkup
|
Q1 2007 |
Q1 2006 |
Change* | |
|---|---|---|---|
|
Gross Margin |
49.9% |
43.3% |
6.6 |
|
Operating Margin |
21.4% |
(56.6%) |
78.0 |
|
Net Margin |
16.4% |
(60.3%) |
76.8 |
Margins are the earnings engine. See how they work.
|
Assets |
Q1 2007 |
Q1 2006 |
Change |
|---|---|---|---|
|
Cash + ST Invest. |
$2,600.0 |
$1,900.0 |
36.9% |
|
Accounts Rec. |
No Data |
No Data |
No Data |
|
Inventory |
No Data |
No Data |
No Data |
Data not available for liabilities
Learn the ways of the balance sheet.
Cash Flow Highlights
|
Q1 2007 |
Q1 2006 |
Change | |
|---|---|---|---|
|
Cash From Ops. |
$499.0 |
$288.5 |
73.0% |
|
Capital Expenditures | $221.0 | $72.4 |
205.3% |
|
Free Cash Flow | $278.0 | $216.1 |
28.6% |
Free cash flow is a Fool's best friend.
Related Foolishness:
Need new ideas for your money? Investors like you rate thousands of stocks on Motley Fool CAPS to help you with your own stock selections. It's fun --and it's free.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.
